Polysubstance Addiction Treatment

Using more than one substance can create risks that are difficult to predict. A person may intentionally combine drugs, use different substances at different times, or unknowingly take a product containing fentanyl or another added substance. The Centers for Disease Control and Prevention defines polysubstance use as exposure to more than one drug, whether intentional or unintentional.

Treatment is not simply a matter of choosing which drug is the “main problem.” A safe plan considers the full pattern of use, possible withdrawal from each substance, medication interactions, overdose history, physical health, mental health, and the person’s recovery environment. Because some combinations can suppress breathing, raise heart rate and blood pressure, or mask intoxication, the first stage of care may require urgent medical evaluation.

When to seek emergency help

Call 911 immediately if someone is difficult to wake, is not breathing normally, has blue or gray lips or fingertips, is having a seizure, has severe chest pain, is extremely confused, or may have overdosed. Administer naloxone when an opioid overdose is possible and naloxone is available. Naloxone can reverse the opioid portion of an overdose, but it does not reverse the effects of benzodiazepines, alcohol, stimulants, or other substances. Emergency medical care is still required.

Do not leave the person alone. Follow the dispatcher’s instructions, provide rescue breathing or CPR if trained, and give additional naloxone doses as directed when the person does not respond.

Why mixing substances is especially dangerous

Different substances can affect the body in overlapping or opposing ways. Opioids, benzodiazepines, alcohol, and other central nervous system depressants can slow breathing. The FDA warns that combining opioids with benzodiazepines or alcohol can cause profound sedation, respiratory depression, coma, and death.

Stimulants such as cocaine or methamphetamine can increase heart rate and blood pressure. Combining stimulants with depressants does not make the effects cancel each other out. One drug may mask warning signs from another, which can lead a person to take more and increase the risk of overdose, heart rhythm problems, stroke, overheating, or other medical emergencies.

Unintentional exposure is also important. Counterfeit pills and illegal drug supplies may contain fentanyl, xylazine, or other substances that a person did not expect. This is one reason a treatment assessment should include a detailed substance history and, when clinically appropriate, toxicology testing.

What a complete assessment includes

A thorough assessment usually reviews:

• Every substance used, including alcohol, prescription medicines, over-the-counter products, nicotine, and supplements
• Dose, frequency, route of use, and time of last use
• Past withdrawal symptoms, seizures, delirium, or severe agitation
• Prior overdoses and naloxone use
• Current medications and possible interactions
• Pregnancy status when relevant
• Medical conditions, pain, sleep problems, and nutritional concerns
• Depression, anxiety, trauma symptoms, psychosis, suicidal thoughts, and other mental health needs
• Housing, transportation, family support, legal concerns, and access to ongoing care

The goal is to identify immediate danger and choose the safest level of care. A person may need hospital treatment, medically managed withdrawal care, residential treatment, intensive outpatient care, standard outpatient care, or a combination over time.

Detox and withdrawal management

“Detox” is often used to describe the early period when substances leave the body. Clinically, withdrawal management is more precise because the goal is not only to stop use but also to monitor and treat withdrawal safely.

Withdrawal risk depends on the substances involved. Alcohol and benzodiazepine withdrawal can be life-threatening and may cause seizures or delirium. These substances should not be stopped abruptly without medical guidance when physical dependence is possible. Opioid withdrawal is usually not fatal by itself, but it can be intensely uncomfortable and can increase the risk of rapid return to use and overdose. Stimulant withdrawal may involve severe fatigue, depression, agitation, sleep disturbance, and suicidal thoughts.

There is no single detox protocol for polysubstance use. Clinicians prioritize the most medically dangerous withdrawal risks, monitor vital signs and mental status, and adjust the plan as symptoms change. Medications may be used to reduce withdrawal symptoms, prevent complications, or begin longer-term treatment.

Medications may be part of treatment

Medication decisions are based on the substances involved and the person’s health. For opioid use disorder, FDA-approved medications include buprenorphine, methadone, and naltrexone. These medications can reduce opioid use and overdose risk when used as part of appropriate care.

There is no FDA-approved medication that treats all forms of polysubstance use at once. A person may receive medication for one substance use disorder, withdrawal symptoms, or a co-occurring mental health condition while also participating in counseling and recovery support. Medication management should account for sedation, breathing risk, liver or kidney function, and interactions with other prescribed or nonprescribed substances.

People taking benzodiazepines should not stop them suddenly without medical supervision. The FDA notes that abrupt discontinuation or rapid dose reduction can cause serious withdrawal reactions, including seizures. A gradual, individualized taper may be needed.

Therapy and behavioral treatment

Behavioral treatment helps identify what each substance is doing in a person’s life. One drug may be used to reduce anxiety, another to stay awake, and another to manage withdrawal from the first. Treatment is more effective when it addresses these functions rather than treating all use as a single behavior.

Common approaches may include cognitive behavioral therapy, motivational interviewing, contingency management, relapse-prevention planning, family education, and trauma-informed care. The treatment team may also address sleep, pain, grief, housing instability, employment, and other pressures that affect recovery.

When mental health symptoms are present, integrated care is important. Depression, anxiety, post-traumatic stress, bipolar disorder, attention-deficit/hyperactivity disorder, and psychotic symptoms can influence substance use and treatment response. Symptoms should be assessed carefully because intoxication and withdrawal can sometimes resemble or intensify psychiatric conditions.

Choosing the right level of care

The safest setting depends on medical risk, withdrawal history, current symptoms, home environment, and ability to attend treatment consistently.

A higher level of care may be appropriate when there is a history of severe withdrawal, repeated overdose, unstable medical or psychiatric symptoms, pregnancy, unsafe housing, inability to stop using in the current environment, or repeated return to use after lower-intensity treatment.

Outpatient care may be appropriate when withdrawal risk is low, the person is medically stable, transportation is reliable, and there is a safe recovery environment. Treatment intensity can change as needs change. Moving to a higher level of care is not failure; it is a clinical adjustment.

Overdose prevention during and after treatment

Tolerance can fall during detox, hospitalization, residential treatment, incarceration, or any period of reduced use. Returning to a previously used amount can cause overdose. An overdose-prevention plan should include:

• Naloxone access and training for the person and people close to them
• Education about the risk of fentanyl and counterfeit pills
• Avoiding use alone
• Reviewing prescription and nonprescription drug interactions
• A plan for rapid re-entry to treatment after return to use
• Follow-up appointments before discharge

Fentanyl test strips can detect fentanyl in many drug forms, although they do not identify every dangerous substance or guarantee that a product is safe. Harm-reduction tools do not replace treatment, but they can reduce risk while a person works toward recovery.

Continuing care and recovery support

Recovery often requires ongoing support after the most intensive phase of treatment ends. Continuing care may include outpatient counseling, medication appointments, peer support, recovery housing, primary care, family support, and help with transportation or employment.

A return to use should trigger reassessment rather than shame. The treatment plan may need a different level of care, medication adjustment, more frequent contact, a safer living environment, or additional mental health treatment. Polysubstance addiction is treatable, and plans can be revised as new information becomes available.

How to find treatment

FindTreatment.gov lists substance use and mental health treatment facilities in the United States. When contacting a program, ask whether it can manage withdrawal from all substances involved, provide medications for opioid use disorder when indicated, treat co-occurring mental health conditions, and coordinate medical care.

For immediate emotional crisis or suicidal thoughts, call or text 988. For overdose, breathing problems, seizures, severe confusion, or another medical emergency, call 911.

Frequently Asked Questions

Is polysubstance addiction a separate diagnosis?

Clinicians diagnose specific substance use disorders based on the substances and symptoms involved. “Polysubstance use” describes the use or exposure pattern and helps communicate that more than one substance must be considered in assessment and treatment.

Does someone have to use multiple drugs at the same time?

No. Polysubstance use can involve substances taken together, within a short period, or at different times. It can also be unintentional when a drug contains an unexpected substance.

Can one detox program manage every combination?

Not necessarily. Programs differ in medical staffing, medication access, and ability to manage severe alcohol, benzodiazepine, opioid, or stimulant withdrawal. A medical assessment should determine the safest setting.

Can naloxone help in a mixed-drug overdose?

Naloxone can reverse opioid effects and should be given when opioid exposure is possible. It will not reverse non-opioid effects, so emergency medical care is still necessary.

What happens if a person returns to use after treatment?

The person should reconnect with care as soon as possible. The team can reassess overdose risk, withdrawal risk, medications, triggers, mental health symptoms, and level of care without treating return to use as a moral failure.

Sources

1. CDC, Polysubstance Use Facts: https://www.cdc.gov/stop-overdose/caring/polysubstance-use.html
2. CDC, Polysubstance Overdose: https://www.cdc.gov/overdose-prevention/about/polysubstance-overdose.html
3. CDC, About Overdose Prevention: https://www.cdc.gov/overdose-prevention/about/
4. SAMHSA, Substance Use Disorder Treatment: https://www.samhsa.gov/substance-use/treatment
5. FindTreatment.gov: https://findtreatment.gov/
6. FDA, Risks of combining opioids with benzodiazepines or alcohol: https://www.fda.gov/drugs/information-drug-class/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and
7. FDA, Benzodiazepine boxed warning and withdrawal risks: https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
8. CDC, Naloxone and overdose resources: https://www.cdc.gov/stop-overdose/caring/index.html